Small Cap U.S. Stocks with Positive and Negative Sentiment on July 2, 2023

Several small cap U.S. stocks appeared in the news on July 2, 2023, with some receiving positive sentiment and others negative.

Positive Sentiment

  • Applied Digital (APLD): The company received FDA clearance for its new product, the CardioMEMS HF System. This is a wireless heart monitoring device that can help patients with heart failure manage their condition.
  • TG Therapeutics (TGTX): The company announced positive results from its Phase 3 clinical trial of its cancer drug, Ublituximab. This drug is being developed to treat chronic lymphocytic leukemia.
  • Immunovant (IMVT): The company announced it has entered into a collaboration agreement with Regeneron Pharmaceuticals to develop and commercialize its novel gene therapy for the treatment of a rare form of arthritis.

Negative Sentiment

  • CTI BioPharma (CTIB): The company received a complete response letter from the FDA for its cancer drug, liso-cel. This means that the FDA has requested additional information before approving the drug.
  • Mirati Therapeutics (MRTX): The company announced that its Phase 3 clinical study of its lung cancer drug, adagrasib, did not meet its primary endpoint. This means that the drug is not as effective as originally hoped.
  • Ellington Financial (EFC): The company revised its financial guidance for the second quarter of 2023. The company now expects to report a loss per share of $0.45 to $0.55, compared to its previous guidance of $0.35 to $0.45.

It is important to note that these are just a few examples of the many small cap U.S. stocks that appeared in the news on July 2, 2023. The sentiment of the news articles may change over time, and the impact on the stock price may not be immediate. Investors should always do their own research before making any investment decisions.

Title: Small Cap U.S. Stocks with Positive and Negative Sentiment on July 2, 2023